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A 66-year-old woman, recently diagnosed with T cell
prolymphocytic leukaemia (PLL) was admitted for
cytotoxic therapy, with a potassium (Kq) of 5.5
mmol/L on admission as measured on a lithium hep-
arin plasma sample (Beckman DxC800; Beckman
Coulter Diagnostics, Fullerton, CA, USA). The sample
was analysed within 70 min of collection. The white
blood cell count (WBC) was 460=109/L (Sysmex XE-
5000; Sysmex, Kobe, Japan). The full biochemistry
results excluded acidosis, renal failure, tumour lysis
syndrome, IV contamination, haemolysis, or EDTA
contamination, and the patient had a normal ECG.
The elevated Kq result led to commencement of reso-
nium to lower the Kq, and this continued until day 2.
Resonium (A) is a cation-exchange resin which lowers
the blood potassium level by exchanging potassium
for sodium in the intestine. On day 2, a Kq of
9.0 mmol/L was obtained, and the result was imme-
diately phoned to the clinical unit. The medical staff
were appropriately notified that this result was prob-
ably artefactual and the resonium was ceased after a
venous blood gas sample was collected, and a Kq of
4.0 mmol/L obtained (Rapidlab 1265; Siemens Health-
care Diagnostics, Medfield, MA, USA).
Pseudohyperkalaemia is well-documented in hyper-
leukocytosis, particularly with chronic lymphocytic
leukaemia (CLL) (1–3). Despite most haematologists
and emergency physicians being aware of this phe-
nomenon, under some circumstances hyperkalaemia
might be misinterpreted. We frequently observe ini-
tiation of treatment to lower Kq, usually in Emergency
or Haematology Units, with the potential to cause in
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vivo hypokalaemia. Unfortunately, they are not aided
in a timely manner in many instances by biochemistry
staff who do not routinely check for elevated white
blood cell (WBC) with elevated Kq.
In CLL, leukocytes exhibit increased fragility to
mechanical stresses (4). This phenomenon has also
been observed with acute lymphoblastic leukaemia
(ALL) (5–7), and PLL (8). Even minor mechanical
stress, such as prolonged tourniquet application,
vacutainer collection, vigorous aspiration or dispen-
sation through a syringe, centrifugation or shaking by
hand, or transport via pneumatic systems (accelerat-
ing or decelerating rapidly) can result in cell lysis and
release of cellular contents wKq, lactate dehydrogen-
ase (LDH), aspartate transaminase (AST)x, as demon-
strated by our data (Table 1). Additionally, delays in
centrifugation, especially of unrefridgerated speci-
mens, prior to analysis will result in significant chang-
es to the Kq, LDH and glucose concentrations. The
glucose on the blood gas analyser indicated the pres-
ence of interfering substances. The patient had
received paracetamol which is documented as an
interfering substance in the analyser manual.
It is well known that Kq is higher in serum due to
platelet release as a result of platelet rupture during the
clotting process (9). For this reason, plasma is the pre-
ferred sample for the determination of Kq concentra-
tion (9). As demonstrated by our data, in samples with
markedly elevated WBCs, serum provides more accu-
rate estimate of Kq, LDH and AST. A likely reason is
the clotting process locks the WBCs in the clot, elim-
inates cell movement during mechanical stress pro-
cesses and minimises lysis. Although others have
postulated the converse: that the clotting process
increases rupture of fragile leukocytes and results in
increased release of Kq (10).
In summary, in patients with hyperleukocytosis,
serum and venous blood gas samples may provide
more accurate estimates of Kq and other analytes,
compared to lithium heparin plasma. Tubes contain-
ing gel separator may be preferred to minimise
cellular contact with plasma post centrifugation. Sam-
ples must be analysed with minimal delay, and pneu-
matic transport systems should not be used to
transport samples. High Kq results should be urgently
rechecked, taking into account the above specimen
requirements before potentially misguided Kq low-
ering therapy is instituted. Finally, as these data were
obtained from a single patient, the results may not be
valid for all patients. Laboratories should consider
completing studies on their own patients using their
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own collection tubes under their own particular pre-
analytical conditions to determine the effects.
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